794 related articles for article (PubMed ID: 20713126)
1. Preclinical and clinical research on inflammation after intracerebral hemorrhage.
Wang J
Prog Neurobiol; 2010 Dec; 92(4):463-77. PubMed ID: 20713126
[TBL] [Abstract][Full Text] [Related]
2. Microglial Polarization and Inflammatory Mediators After Intracerebral Hemorrhage.
Zhang Z; Zhang Z; Lu H; Yang Q; Wu H; Wang J
Mol Neurobiol; 2017 Apr; 54(3):1874-1886. PubMed ID: 26894396
[TBL] [Abstract][Full Text] [Related]
3. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation.
Zhou Y; Wang Y; Wang J; Anne Stetler R; Yang QW
Prog Neurobiol; 2014 Apr; 115():25-44. PubMed ID: 24291544
[TBL] [Abstract][Full Text] [Related]
4. Inflammation after intracerebral hemorrhage.
Wang J; Doré S
J Cereb Blood Flow Metab; 2007 May; 27(5):894-908. PubMed ID: 17033693
[TBL] [Abstract][Full Text] [Related]
5. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
Wu CH; Shyue SK; Hung TH; Wen S; Lin CC; Chang CF; Chen SF
J Neuroinflammation; 2017 Nov; 14(1):230. PubMed ID: 29178914
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage.
Ma B; Day JP; Phillips H; Slootsky B; Tolosano E; Doré S
J Neuroinflammation; 2016 Feb; 13():26. PubMed ID: 26831741
[TBL] [Abstract][Full Text] [Related]
7. Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies.
Wagner KR; Hua Y; de Courten-Myers GM; Broderick JP; Nishimura RN; Lu SY; Dwyer BE
Cell Mol Biol (Noisy-le-grand); 2000 May; 46(3):597-608. PubMed ID: 10872746
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway.
Wei CC; Kong YY; Li GQ; Guan YF; Wang P; Miao CY
Sci Rep; 2017 Apr; 7(1):717. PubMed ID: 28386082
[TBL] [Abstract][Full Text] [Related]
9. Matrix Metalloproteinases in Acute Intracerebral Hemorrhage.
Lattanzi S; Di Napoli M; Ricci S; Divani AA
Neurotherapeutics; 2020 Apr; 17(2):484-496. PubMed ID: 31975152
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of Drugs Targeting Pathophysiology of Intracerebral Hemorrhage: From Animal Models to Clinical Applications.
Liao KH; Sung CW; Huang YN; Li WJ; Yu PC; Wang JY
Curr Pharm Des; 2017; 23(15):2212-2225. PubMed ID: 27799045
[TBL] [Abstract][Full Text] [Related]
11. Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update.
Ren H; Han R; Chen X; Liu X; Wan J; Wang L; Yang X; Wang J
J Cereb Blood Flow Metab; 2020 Sep; 40(9):1752-1768. PubMed ID: 32423330
[TBL] [Abstract][Full Text] [Related]
12. Mannitol and Hypertonic Saline Reduce Swelling and Modulate Inflammatory Markers in a Rat Model of Intracerebral Hemorrhage.
Schreibman DL; Hong CM; Keledjian K; Ivanova S; Tsymbalyuk S; Gerzanich V; Simard JM
Neurocrit Care; 2018 Oct; 29(2):253-263. PubMed ID: 29700692
[TBL] [Abstract][Full Text] [Related]
13. The deleterious or beneficial effects of different agents in intracerebral hemorrhage: think big, think small, or is hematoma size important?
Keep RF; Xi G; Hua Y; Hoff JT
Stroke; 2005 Jul; 36(7):1594-6. PubMed ID: 15933250
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats.
Chang CY; Kuan YH; Li JR; Chen WY; Ou YC; Pan HC; Liao SL; Raung SL; Chang CJ; Chen CJ
J Nutr Biochem; 2013 Dec; 24(12):2127-37. PubMed ID: 24139673
[TBL] [Abstract][Full Text] [Related]
15. Progress in translational research on intracerebral hemorrhage: is there an end in sight?
Xi G; Strahle J; Hua Y; Keep RF
Prog Neurobiol; 2014 Apr; 115():45-63. PubMed ID: 24139872
[TBL] [Abstract][Full Text] [Related]
16. Iron and iron-handling proteins in the brain after intracerebral hemorrhage.
Wu J; Hua Y; Keep RF; Nakamura T; Hoff JT; Xi G
Stroke; 2003 Dec; 34(12):2964-9. PubMed ID: 14615611
[TBL] [Abstract][Full Text] [Related]
17. Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within?
Righy C; Bozza MT; Oliveira MF; Bozza FA
Curr Neuropharmacol; 2016; 14(4):392-402. PubMed ID: 26714583
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 EP2 receptor deletion attenuates intracerebral hemorrhage-induced brain injury and improves functional recovery.
Leclerc JL; Lampert AS; Diller MA; Immergluck JB; Doré S
ASN Neuro; 2015; 7(2):. PubMed ID: 25873308
[TBL] [Abstract][Full Text] [Related]
19. Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor.
Leclerc JL; Ahmad AS; Singh N; Soshnik-Schierling L; Greene E; Dang A; Doré S
BMC Neurosci; 2015 Aug; 16():48. PubMed ID: 26232001
[TBL] [Abstract][Full Text] [Related]
20. Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment.
Wasserman JK; Zhu X; Schlichter LC
Brain Res; 2007 Nov; 1180():140-54. PubMed ID: 17919462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
